Consumption of Apitherapy Products by Late Adolescents Before and During the COVID-19 Pandemic: A Cross-Sectional and Comparative Descriptive Study

Author:

Aksoy BaharORCID,Apaydın Cırık VildanORCID

Abstract

Background: Apitherapy has emerged as both a conventional and alternative treatment effective against COVID-19-related symptoms. Objectives: This study aimed to determine the types, frequency, and amount of apitherapy products that late adolescents use before and during the pandemic. Methods: The study employed a cross‐sectional, descriptive, and comparative design. Using stratified random sampling, 3307 late adolescents aged 17 - 21 were included. Data were collected through a questionnaire on demographic characteristics and apitherapy products. Descriptive statistics and paired sample t-tests were used for data analysis, with effect size calculated using Cohen’s d method. Results: Half of the participants (n = 1595, 48.2%) had never heard of “apitherapy” before, while those who had heard mentioned honey (35.6%), pollen (25.5%), propolis (14.9%), royal jelly (11.3%), bee venom (8.4%), and bee bread (4.3%). They reported using these products to “boost their immune systems”, “prevent respiratory infections/reduce cough”, and “reduce nausea and vomiting”. Late adolescents consumed significantly more honey (t = -15.683, P < 0.001, effect size = 0.35), pollen (t = -11.111, P < 0.001; effect size = 0.44), and propolis (t = -15.302, P < 0.001, effect size = 0.45) during the pandemic than before. They primarily examined labels before purchasing (36.4%) and believed that products approved by the Ministry of Agriculture and Forestry should be purchased (63.3%). Conclusions: This study underscores the popularity of apitherapy among late adolescents. Further surveys are recommended to better understand young people's apitherapy habits and provide valuable data for healthcare practitioners combating the pandemic.

Publisher

Briefland

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3